ARCHIVES

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

Cancer “Report Card”: Growing Population Of Cancer Survivors Creates Need For New Research Emphasis, NCI Director Says

March 20, 1998

Counseling reduces Pain, Study Shows

April 18, 1986

Campus-Dweller Rabson Finds Comfort In NIH Security.

December 14, 2001

HHS To Announce Final Plan For Coverage Of Patient Care Costs In All Clinical Trials.

July 28, 2000

DCT Advisors Approve Five Trials For High Priority Status

April 7, 1995